SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Forastiere A, Kock W, Trotti A, Sidransky D. Medical progress: head and neck cancer. N Engl J Med. 2001; 345: 18901900.
  • 2
    Domenge C, Hill C, Lefebvre J, et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. Br J Cancer. 2000; 83: 15941598.
  • 3
    Lefebvre J, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer Phase III trial. J Natl Cancer Inst. 1996; 88: 890898.
  • 4
    Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991; 324: 16851689.
  • 5
    Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst. 1999; 91: 20812086.
  • 6
    Paccagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in Stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst. 1994; 86: 265272.
  • 7
    Dreyfuss A, Clark J, Norris C, et al. Docetaxel: an active drug for squamous cell carcinoma of the head and neck. J Clin Oncol. 1996; 14: 16721678.
  • 8
    Catimel G, Verwij J, Hanauske A. Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. Ann Oncol. 1994; 5: 553537.
  • 9
    Couteau C, Leyvraz S, Oulid-Aissa D, et al. A Phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck. Br J Cancer. 1999; 81: 457462.
  • 10
    Colevas A, Busse P, Norris C, et al. Induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil, and leucovorin (TPFL5) for squamous cell carcinoma of the head and neck: a Phase I/II trial. J Clin Oncol. 1998; 16: 13311339.
  • 11
    Colevas A, Norris C, Tishler R, et al. A Phase II trial of TPFL (docetaxel, cisplatin, 5-fluorouracil, leucovorin) as induction for squamous cell carcinoma of the head and neck (SCCHN). J Clin Oncol. 1999; 17: 35033511.
  • 12
    Colevas A, Norris C, Tishler R, et al. A Phase I/II Study of outpatient docetaxel, cisplatin, 5-fluorouracil, and leucovorin (op-TPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN). Am J Clin Oncol. 2002; 25: 153159.
  • 13
    Posner M, Glisson B, Frenette G, et al. A multi-center Phase I–II trial of docetaxel, cisplatinum, and 5-fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. J Clin Oncol. 2001; 19: 10961104.
  • 14
    Forastiere AA, Berkey B, Maor M, et al. Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone. Intergroup Trial R91-11 [abstract]. Proc Am Soc Clin Oncol. 2001; 20: 2a.
  • 15
    Calais G, Alfonsi M, Bardet E, et al. Radiation alone (RT) versus RT with concomitant chemotherapy (CT) in Stages III and IV oropharynx carcinoma. Final results of the 94-01 GORTEC randomized study. Proceedings of the 43rd annual ASTRO meeting, 2001. Int J Radiat Oncol Biol Physics. 2001; 51(Suppl 1): 12.
  • 16
    Fu K, Pajak T, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000; 48: 716.
  • 17
    Posner M. Sequential chemotherapy for the curative treatment of squamous cell cancer of the head and neck: a new paradigm. Oncol Spectrums. 2001; 2: 193202.
  • 18
    Posner M, Colevas A, Tishler R. The role of induction chemotherapy in the curative treatments of squamous cell cancer of the head and neck. Semin Oncol. 2000; 27(Suppl G): 1324.
  • 19
    Vokes E, Kies M, Rosen F, et al. Induction chemotherapy followed by concomitant chemoradiotherapy for Stage IV head and neck cancer: an attempt at locoregional and systemic tumor control. Proc Am Soc Clin Oncol. 2000; 19: 1653.
  • 20
    Gray J, Meluch A, Greco F, et al. Induction paclitaxel/carboplatin/5FU followed by concurrent radiotherapy and weekly paclitaxel/carboplatin for patients with locally advanced head and neck cancer (HNC): a Minnie Pearl Cancer Research Network trial [abstract]. Proc Am Soc Clin Oncol. 2001; 20: 226a.